These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22783792)

  • 1. The current system for prescribing antiretroviral therapy puts HIV-infected patients at risk of serious drug-drug interactions: is now the time for a paradigm shift in HIV care delivery?
    Whitlock GG; Patel A; Edwards SG; Benn PD; Miller RF
    Clin Med (Lond); 2012 Jun; 12(3):300-1. PubMed ID: 22783792
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid lowering therapy in patients with HIV infection.
    Wierzbicki AS; Reynolds TM; Crook MA; Tatler J; Peters BS
    Lancet; 1998 Nov; 352(9142):1782. PubMed ID: 9848376
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral availability of fluticasone propionate.
    Andersson P; Brattsand R; Dahlström K; Edsbäcker S
    Br J Clin Pharmacol; 1993 Aug; 36(2):135-6. PubMed ID: 8398584
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic bioavailability of fluticasone proprionate.
    Lipworth BJ
    Br J Clin Pharmacol; 2001 Oct; 52(4):457-60. PubMed ID: 11678793
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serious adverse events derived from the drug interactions of antiretroviral therapy].
    Morales Conejo M; Moreno Cuerda VJ; Abellán Martínez J; Rubio R
    Rev Clin Esp; 2008 Dec; 208(11):557-60. PubMed ID: 19121266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oral systemic availability of fluticasone propionate in man--preliminary data.
    Bye A
    Br J Clin Pharmacol; 1993 Aug; 36(2):136-7. PubMed ID: 8398585
    [No Abstract]   [Full Text] [Related]  

  • 7. Epilepsy: Issues with antiepileptic drug use in HIV-infected patients.
    Brew BJ; Thompson J
    Nat Rev Neurol; 2012 Mar; 8(4):187-8. PubMed ID: 22410581
    [No Abstract]   [Full Text] [Related]  

  • 8. Absorption of high-dose inhaled corticosteroids.
    Brutsche-Carlen M; Carlen-Brutsche I; Woodcock A
    Chest; 2000 May; 117(5):1526. PubMed ID: 10807856
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Dose proportionality of fluticosone proportionate hydrofluoroalkane pressurized metered dose inhalers (pMDIS) and comparability with chlorofluorocarbon pMDIS.
    Lipworth BJ
    Respir Med; 2001 Feb; 95(2):160-3. PubMed ID: 11217914
    [No Abstract]   [Full Text] [Related]  

  • 10. Iatrogenic Cushing's syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen.
    Clevenbergh P; Corcostegui M; Gérard D; Hieronimus S; Mondain V; Chichmanian RM; Sadoul JL; Dellamonica P
    J Infect; 2002 Apr; 44(3):194-5. PubMed ID: 12099750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic effects of inhaled steroids.
    Lipworth BJ
    Thorax; 2001 Dec; 56(12):980-1. PubMed ID: 11758508
    [No Abstract]   [Full Text] [Related]  

  • 12. Key Principles of Antiretroviral Pharmacology.
    Dionne B
    Infect Dis Clin North Am; 2019 Sep; 33(3):787-805. PubMed ID: 31395145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic bioavailability of fluticasone in COPD.
    Lipworth BJ; Menzies D
    Am J Respir Crit Care Med; 2005 May; 171(10):1191; author reply 1191-2. PubMed ID: 15879430
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology.
    Affrime MB; Banfield C; Nolop K
    Eur Respir J; 2001 Jul; 18(1):246. PubMed ID: 11510799
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluticasone and asthma.
    Edsbäcker S; Thorsson L
    Lancet; 2001 Mar; 357(9258):804. PubMed ID: 11253999
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic bioavailability of inhaled steroids: the importance of appropriate and comparable methodology.
    Derendorf H; Daley-Yates PT; Pierre LN; Efthimiou J
    Eur Respir J; 2001 Jan; 17(1):157-8. PubMed ID: 11307748
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo.
    Esmailpour N; Högger P; Rabe KF; Heitmann U; Nakashima M; Rohdewald P
    Eur Respir J; 1997 Jul; 10(7):1496-9. PubMed ID: 9230236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of fibrates in the management of hyperlipidemia in HIV-infected patients receiving HAART.
    Calza L; Manfredi R; Chiodo F
    Infection; 2002 Jan; 30(1):26-31. PubMed ID: 11876511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reversibility of severe hyperlipemia secondary to indinavir with micronized phenofibrate].
    de Luis DA; Aller R; Rachiller P; Ignacio Tortosa J
    Med Clin (Barc); 1999 Nov; 113(18):716-7. PubMed ID: 10650577
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactions between antifungal and antiretroviral agents.
    Hughes CA; Foisy M; Tseng A
    Expert Opin Drug Saf; 2010 Sep; 9(5):723-42. PubMed ID: 20345324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.